Purpose: To quantify the ex vivo production of proangiogenic proteins (vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), urokinase-type plasminogen activator (u-PA), tissue-type plasminogen activator (tPA)) and angiogenesis inhibitors (plasminogen activator inhibitor type-1 (PAI-1) and angiostatin) from epithelial and stromal components of primary prostate cancer (CaP) and benign prostatic hyperplasia (BPH) cultures. To perform microvessel density (MVD) counts on sections of BPH and CaP from the same prostatectomy specimens. Scope: Angiogenic cytokine expression was measured by immunoassays and in vitro angiostatin generating capacities assessed using immunoblotting. CaP and BPH tissue was immunostained using factor VIII antibody to determine MVD. Conclusions: Elements regulating angiogenesis are present in both primary cultures of CaP and BPH, suggesting that angiogenic ability is well established in the absence of carcinoma.
Introduction
Tumor neovascularization contributes to prostate cancer (CaP) progression, facilitating the growth and metastasis of this tumor. The angiogenic phenotype results from the interaction of proangiogenic and antiangiogenic factors and is dependent on a net balance of the positive and negative regulators present in this environment. Critical to this process is the ability for tumor or stromal cells to secrete angiogenic proteins, an initiating step in vascular hyperpermeability, protease secretion, capillary basement membrane breakdown, and endothelial cell migration and proliferation. 1, 2 In addition, the angio-genic phenotype in vivo as reflected by microvessel density (MVD) can be monitored using immunohistochemical techniques. Reports suggest that MVD is increased in CaP specimens as compared to benign prostatic hyperplasia (BPH) tissue, and that MVD is an independent predictor of pathologic stage in patients with CaP. 3 Angiogenic potential of epithelial and stromal components in vitro has not, to our knowledge, been reported and is important in the paracrine regulation of the angiogenic environment.
Prostatic epithelial differentiation is dictated by the surrounding stroma. Androgen-induced growth and expression of secretory proteins in the normal prostate are determined by the prostatic stroma. 4 Knowledge regarding cellular interaction between the prostatic epithelial cells and stroma may help in understanding the biology of BPH and CaP. 5 Chung and associates demonstrated that stromal-epithelial interaction is of fundamental significance in CaP growth and invasion. 6 Expression of vascular endothelial cell growth factor (VEGF) has been associated with a number of experimental and human tumors and shown to affect the proliferation, migration, and vascular permeability of endothelial cells, and is an inducer of in vitro angiogenesis. 7, 8 However, conflicting immunohistochemical (IHC) data show both increased expression of VEGF in CaP specimens, but not in normal or BPH specimens, and widespread distribution of VEGF staining in CaP and BPH specimens. 9, 10 Basic fibroblast growth factor (bFGF) induces endothelial cell proliferation, migration, and protease expression. 11 The level of bFGF protein in whole tumor extracts of CaP is higher than that in extracts of uninvolved prostate peripheral zone tissue. 12 Increased urokinase-type plasminogen activator (u-PA) levels have been found in in vitro CaP cell lines with high metastatic potential. 13 The increase of u-PA expression has been found in cancer specimens with extracapsular extension vs specimens without extracapsular extension.
14 The secretion of u-PA from endothelial cells facilitates the degradation of tumor matrix and establishes neovascularization. 15 Evans et al have shown that expression of a mutant, proteolytically inactive form of u-PA significantly decreases CaP tumor growth and angiogenesis in vivo. 16 Angiostatin is a fragment of plasminogen 17 and its production from a Lewis lung carcinoma (LLC-LM) primary tumor suppressed the growth of metastases. 18 The plasminogen-activator system is involved in converting plasminogen to angiostatin in vitro. It has been demonstrated that angiostatin can be generated by established human cell lines of melanoma, bladder, colon, cervical, breast, and ovarian carcinomas, 19 the CaP cell line PC-3, a pancreatic-cancer cell line, 20 as well as activated macrophages. 21, 22 The proteolytic enzymes, u-PA, tPA, elastase, metalloproteinases (MMPs), 23 and prostate-specific antigen 24 can also be involved in angiostatin generation.
We hypothesized that epithelial and stromal components of CaP and BPH growing in primary cell cultures each possess the ability to regulate angiogenesis, which would be reflected in their MVD counts. The objectives of this study were two-fold: (1) to measure VEGF, bFGF, u-PA, tPA, and PAI-1 secretion, and in vitro angiostatingenerating capacities of epithelial and stromal components of primary CaP and BPH cultures and (2) perform MVD counts on sections of BPH and CaP from the same prostatectomy specimens. We sought to quantitate and compare angiogenic regulators and neovascularity in these cell components.
Materials and methods

Primary epithelial and stromal cell cultures
Prostate specimens were obtained from 58 patients undergoing radical retropubic prostatectomy for clinically localized prostate cancer at the University of California, Davis Medical Center. Tissue from visible and palpable cancer nodules or BPH adenomas were dissected using optical magnification by a single surgeon (CPE). BPH nodules were dissected from the transition zone. Mirror image adjacent sections of CaP and BPH tissue were taken for paraffin embedding and histological analysis. Only specimens with mirror image confirmation of all CaP or all BPH were included. All samples were washed in DBSS, minced into 1 mm pieces with a scalpel and centrifuged at 2500 r.p.m. (B1000 g) for 5 min. Samples were resuspended in PrEBM medium (Clonetics, San Diego) without serum, but containing 10 ng/ml collagenase (#C-0130, Sigma, St Louis) and 10 nM Ca 2+ and incubated on a rotary shaker at 371C for 4 h. After that, samples were centrifuged, washed twice in DBSS and placed into 60 mm tissue culture plates containing one of the two culture media: MCDB 104 medium (Sigma, St Louis) containing 10% fetal bovine serum, penicillin 100 U/ml, and streptomycin 100 mg/ ml, or PrEGM medium (Clonetics, San Diego) containing 10 ng/ml cholera toxin (Sigma, St Louis) and incubated at 371C, 5% CO 2 . MCDB 104 selects for prostate stromal cell growth and PrEGM for epithelial cell growth, yielding the two cell populations as described by Peehl. 25 Cultures were passaged 2 times before 24 h serum-free conditioned media (CM) was collected. Representative epithelial and stromal cultures were analyzed by immunohistochemistry (IHC) with antibodies against actin, pancytokeratin, pancytokeratin cocktail AE1/AE3 and vimentin to verify the purity of their respective cell populations (results not shown).
26,27
ELISAs CM was assayed for bFGF and VEGF by their respective ELISAs (Quantikine, R&D Systems, Minneapolis) and performed according to the manufacturer's protocols. Levels of tPA and PAI-1 in serum-free CM from tumor cell lines were determined by specific ELISA as described. 26 24 h CM was thawed and assayed for u-PA by ELISA utilizing a quantitative sandwich immunoassay as previously described. At least three batches of serum-free CM from each cell line were tested. Results are per milligram protein and depicted as the means of all measurements with standard error.
Digestion of plasminogen to angiostatin by cell-culture supernatant and angiostatin Western blot
Near confluent cells were incubated in serum-free media (PrEGM or MCDB 104) for 24 h. CM was collected, centrifuged, and frozen at À401C until analyzed. CM was equalized by protein assay and plasminogen (Sigma) was added to CM at a final concentration of 25 mg/ml and incubated at 371C for the indicated periods of time. From each cell line at least three batches of CM were tested for angiostatin generation.
SDS-PAGE and Western blotting were performed as previously described by us. 19 The degree of angiostatin formation was determined semiquantitatively by the time point at which angiostatin formation was first observed, the intensity of angiostatin bands, and decrease of plasminogen band intensity as described. 19 Angiogenesis in BPH and prostate cancer S-J Shih et al
In general, a cell line was considered to be an intermediate producer of angiostatin when plasminogen was only partly converted to angiostatin after a 24 h incubation period. A cell line inducing complete conversion of plasminogen to angiostatin after 24 h and/or formation of angiostatin after 8 or even 3 h of incubation was considered to be a potent angiostatin generator. 19 
Immunohistochemistry for MVD
CaP and BPH originating from the same radical prostatectomy specimen were immunostained. Four micron tissue sections were deparaffinized in xylene, dehydrated and incubated with 3% H 2 O 2 in absolute methanol for 10 min. Microwave antigen retrieval involved heating rehydrated sections in 0.01 M citrate buffer (pH adjusted to 6.0) for 3 times 4 min at full-power output (600 W, Sharp-Carousel MW oven) and then cooling to room temperature. In a humidified chamber, sections were incubated for 30 min with 10% heatinactivated normal goat serum followed by polyclonal antisera against human von Willebrand factor or factor VIII-related antigen (Novocastra Laboratories Ltd, Newcastle upon Tyne, UK) at 1:800 overnight at 401C. Sections were then rinsed in phosphate-buffered saline (PBS) and incubated for 60 min at room temperature with a 1:200 dilution of biotinylated goat anti-rabbit immunoglobulin (Vector, Burlingame, CA, USA). A PBS rinse was followed by incubation for 30 min with Vectastain RTU Elite ABC reagent (Vector, Burlingame, CA, USA). Finally, the sections were developed with diaminobenzidine (DAB), rinsed in tap water, counterstained with Mayer's hematoxylin, and coverslipped with a mounting medium. Formalin-fixed sections of human tonsil were used as positive controls; PBS was substituted for the primary antibody as a negative control. Sections were examined by light microscopy (Nikon E400) with a Â 20/0.50 objective lens by a board certified pathologist (RGE). For each sample, 10 fields of view measuring 1.1 mm were assessed which had the highest concentration ('hot spots') of Factor VIII positive vessels. These were then averaged for a composite score per sample.
Statistics
ELISA samples were run in duplicate and experiments repeated 3 times. Values shown are the mean of all experiments, and standard error in the triplicate experiments was found to be o10% of the mean. Comparisons were made by rank-sum analysis at a significance level of Pr0.05.
Results
CaP and BPH cultures from radical retropubic prostatectomy specimens
We included only specimens with histological mirror image confirmation that only CaP or BPH were present. All 18 patients had successful CaP primary cultures established to make up the core CaP sample size, with 11 having Gleason scores !7 (Gleason 7, n ¼ 7; Gleason 8, n ¼ 2; Gleason 9, n ¼ 1; Gleason 10, n ¼ 1) and seven patients had Gleason scores r6 (Gleason 5, n ¼ 1; Gleason 6, n ¼ 6). A total of 33 patients made up the core sample size of BPH tissue derived from the transition zone of radical prostatectomy specimens when the cancer component was Gleason scores !7 in 9 (Gleason 7, n ¼ 7; Gleason 8, n ¼ 2). In all, in 24 patients' BPH tissue came from prostates whose carcinoma had Gleason r6 (Gleason 3, n ¼ 1; Gleason 5, n ¼ 2; Gleason 6, n ¼ 21).
Expression of angiogenic factors
bFGF was not detected in CM from epithelial CaP nor BPH cultures (Table 1) , but was expressed in stromal cultures. The cultured CaP stromal specimens expressed a mean of 51.3711 pg/mg protein and the cultured BPH stromal specimens expressed a mean of 40.6710 pg/mg protein (Table 1 ). There is no statistical difference in the bFGF secretion levels between CaP and BPH stromal Table 2 . Tumor grade did not account for a statistical difference at Pr0.05.
u-PA was secreted to a greater extent by epithelial than stromal cells (Table 1) . Primary CaP epithelium produced a mean of 104725 ng u-PA/mg protein, while primary CaP stroma produced an average of 1573.0 ng u-PA/mg protein. The difference is statistically significant (Po0.05). Likewise, primary BPH epithelium produced a mean of 119725 ng u-PA/mg protein, while primary BPH stroma produced an average of 8.072.0 ng u-PA/mg protein (Po0.05). Stratification of expression by Gleason score was not found to be statistically significant (Table 2) at Pr0.05.
While tPA was not highly expressed by any histologic group, more was detected in stromal as compared to epithelial cultures (Table 1) . PAI-1 was secreted at a similar level in epithelial and stromal compartments. There is no statistical difference between CaP and BPH groups (Table 1) at Pr0.05.
An example of immunoblotting for generation of angiostatin is seen in Figure 1 . Figure 2 shows a compilation of data from all primary prostate cultures. Our results show that angiostatin generation is a common phenomenon in all primary prostate cultures. Of the 90 total BPH and CaP epithelial and stromal cell cultures investigated, 26 (28.8%) were strong angiostatin generators, 33 (36.7%) were intermediate generators, and 31 (34%) were weak. Significant differences were observed between CaP epithelial cultures and CaP stromal cultures. Eight out of 14 (57%) CaP epithelial cultures were strong generators of angiostatin, but only three out of 14 (21.4%) CaP stromal cultures showed some angiostatin generation. In total, 16 of 33 BPH epithelial cultures (48.5%) were intermediate producers, whereas only eight of 29 (27.6%) BPH stromal cultures were intermediate generators. The percentage of strong angiostatin generators among BPH epithelial cultures (nine of 33, 27.3%) were higher than those among BPH stromal cultures (6 of 28, 21.4%). In addition, all stromal cultures were weaker generators as compared to epithelial cultures.
Microvessel density
We found that the mean number of vessels/field was 18.978 and 5.372 in BPH and in CaP, respectively. This 3.5-fold higher MVD in BPH regions from these specimens as compared to areas of CaP ( Figure 3 ) was significant (P ¼ 0.03).
Discussion
In our primary cell culture model, we have demonstrated the expression of angiogenic proteins in human BPH and CaP, suggesting that angiogenic ability is well established in the absence of carcinoma. Furthermore, in our model, both epithelial and stromal cells are shown to be capable of making angiogenic factors. The in vivo environment is multifactorial, complex and likely dynamic in its regulation. Although BPH is not proven Figure 1 Western blot analysis of protein fragments generated by digestion of purified plasminogen by serum-free medium conditioned by two primary BPH-epithelial and two CaP-epithelial cell cultures. Reaction products were analyzed with a polyclonal antiplasminogen antibody, affinity-purified against kringle domains 1-3. Note increased angiostatin generation at 20 h (Epi: epithelial cells). We found increased levels of bFGF expression from the stromal, but not epithelial component of CaP primary culture specimens. Previously, we have described that secreted bFGF from in vitro orthotopically derived cell lines is not detectable. 26 Consistent with this is the recent report that in situ hybridization (ISH) of paraffinembedded CaP samples showed bFGF mRNA only in stromal cells. 28 We found both stromal and epithelial components of CaP and BPH primary culture specimens to express VEGF. However, prior IHC studies localized VEGF to CaP glandular cells in 20/25 specimens. 10 BPH or normal adjacent areas of prostate showed no or significantly diminished staining for VEGF when compared to malignant tissue, suggesting that significant levels of VEGF are present in CaP tumor cells, but not BPH, or normal cells in vivo. 10 Furthermore, Sugamoto found VEGF mRNA only present in adenocarcinoma cells by ISH. 28 Our in vitro model of primary cell cultures demonstrates that BPH cells have the ability to express VEGF. It suggests that a process of bFGF or VEGF expression may be regulated, intermittently activated or turned off in the in vivo BPH prostate gland. Our observations suggest that prostate stroma has the capacity to express growth factors, which may contribute to stromal-epithelial interactions under certain, presently undefined conditions. This has direct therapeutic implications for targeting cell-specific events in BPH and CaP, and deserves further investigation. Additionally, it should be considered that the cultured epithelial and stromal cells are grown in different media. While this could potentially have a variable effect on cytokine production, these culture media and conditions as developed by Peehl 25 are felt to optimize the environment for each cell type.
Our studies show that u-PA is secreted equally by tumor and hyperplastic epithelial components, and to a lesser extent by the stromal cells. However, Kirchheimer et al 29 have demonstrated a higher u-PA activity in CaP metastases, as compared with the corresponding primary tumors, and Miyake et al 30 reported that serum levels of u-PA in patients with prostate cancer were significantly higher than those in patients with BPH. Differences in tumor stage and grade may contribute to this discrepancy.
Although in our study u-PA levels secreted from epithelial cells (stronger angiostatin generators) are higher than those secreted by stromal cells (weaker angiostatin generators), we did not find a clear correlation between CM u-PA concentrations and angiostatin generating capacity (data not shown). In CM from our primary CaP and BPH cultures, enzymatic activity capable of excising angiostatin from purified plasminogen was detectable. In our experiments, we observed that kringles 1-4 contained several forms of angiostatin-like plasminogen fragments with microheterogeneity, possibly reflecting small variations of cleavage sites in the connection peptide region. This would result in multiple angiostatin isoforms. Another possibility is that more than one enzyme may be involved in in vitro angiostatin generation. Different mechanisms may be involved in the generation of angiostatin, since, in our study, angiostatin generation from some CMs is not fully correleated Angiogenesis in BPH and prostate cancer S-J Shih et al
